Horizon Therapeutics
HZNP
#868
Rank
HK$207.32 B
Marketcap
HK$905.35
Share price
0.00%
Change (1 day)
5.72%
Change (1 year)

Earnings for Horizon Therapeutics (HZNP)

Earnings in 2023 (TTM): HK$4.01 Billion

According to Horizon Therapeutics 's latest financial reports the company's current earnings are HK$3.64 Billion. In 2022 the company made an earning of HK$4.75 Billion, an increase over its 2021 earnings that were of HK$4.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Horizon Therapeutics from 2011 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) HK$4.01 B-15.54%
2022 HK$4.75 B12.27%
2021 HK$4.23 B17.91%
2020 HK$3.59 B589.84%
2019 HK$0.52 B42489.17%
2018 HK$1.22 M-100.04%
2017 -HK$3.02 Billion173.37%
2016 -HK$1.11 Billion125.24%
2015 -HK$0.49 Billion-74.45%
2014 -HK$1.92 Billion121.6%
2013 -HK$0.87 Billion42.93%
2012 -HK$0.61 Billion53.74%
2011 -HK$0.4 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
HK$64.17 B 1,508.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$101.90 B 2,453.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$92.26 B 2,212.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$7.15 B 79.30%๐Ÿ‡ฎ๐Ÿ‡ณ India
Merck
MRK
HK$179.74 B 4,404.98%๐Ÿ‡บ๐Ÿ‡ธ USA